Cargando…

LncRNA EIF3J-AS1 functions as an oncogene by regulating MAFG to promote prostate cancer progression

Long non-coding RNAs (lncRNAs) can modulate various biological processes and behaviors in most human cancers. LncRNA EIF3J-AS1 has been reported as an oncogene in various tumors, but whether it exerts functions in malignant progression and gene expression in prostate cancer (PCa) remains unknown. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Chen, Qin, Shengfei, Guo, Fei, Yang, Yue, Wang, Huiqing, Zhang, Chao, Yang, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692703/ https://www.ncbi.nlm.nih.gov/pubmed/34976178 http://dx.doi.org/10.7150/jca.60676

Ejemplares similares

LncRNA MAFG-AS1 is involved in human cancer progression
por: Li, Penghui, et al.
Publicado: (2023)

A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism
por: Pradas-Juni, Marta, et al.
Publicado: (2020)

MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression
por: Li, Peizhang, et al.
Publicado: (2022)

lncRNA MAFG-AS1 Contributes to Esophageal Squamous-Cell Carcinoma Progression via Regulating miR143/LASP1
por: Qu, Yunhui, et al.
Publicado: (2020)

LncRNA MAFG-AS1 Suppresses the Maturation of miR-34a to Promote Glioblastoma Cell Proliferation
por: Zhao, Hao, et al.
Publicado: (2021)

lncRNA MAFG-AS1 Contributes to Esophageal Squamous-Cell Carcinoma Progression via Regulating miR143/LASP1 [Retraction]
Publicado: (2020)

A lncRNA-immune checkpoint-related gene signature predicts metastasis-free survival in prostate adenocarcinoma
por: Ye, Chen, et al.
Publicado: (2022)

Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance
por: Feng, Jing, et al.
Publicado: (2020)

LncRNA MAFG-AS1 Accelerates Cell Migration, Invasion and Aerobic Glycolysis of Esophageal Squamous Cell Carcinoma Cells via miR-765/PDX1 Axis
por: Qian, Cui-juan, et al.
Publicado: (2020)

LncRNA H19: A novel oncogene in multiple cancers
por: Yang, Jun, et al.
Publicado: (2021)

MAFG-AS1 aggravates the progression of pancreatic cancer by sponging miR-3196 to boost NFIX
por: Ye, Liqing, et al.
Publicado: (2020)

LncRNA OGFRP1 acts as an oncogene in NSCLC via miR-4640-5p/eIF5A axis
por: Liu, Xiaojing, et al.
Publicado: (2021)

Oncogenic roles of the lncRNA LINC00460 in human cancers
por: Su, Min, et al.
Publicado: (2022)

LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells
por: Tang, Chenye, et al.
Publicado: (2021)

MAFG-driven osteosarcoma cell progression is inhibited by a novel miRNA miR-4660
por: Shan, Hua-jian, et al.
Publicado: (2021)

LncRNA LINC01512 Promotes the Progression and Enhances Oncogenic Ability of Lung Adenocarcinoma
por: Chen, Jie, et al.
Publicado: (2017)

LncRNA FTX Contributes to the Progression of Colorectal Cancer Through Regulating miR-192-5p/EIF5A2 Axis
por: Zhao, Kui, et al.
Publicado: (2020)

LncRNA-RMRP Acts as an Oncogene in Lung Cancer
por: Meng, Qingjun, et al.
Publicado: (2016)

YAP Inactivation by Soft Mechanotransduction Relieves MAFG for Tumor Cell Dedifferentiation
por: Lv, Jiadi, et al.
Publicado: (2023)

Survival-Related lncRNA Landscape Analysis Identifies LINC01614 as an Oncogenic lncRNA in Gastric Cancer
por: Wu, Huijie, et al.
Publicado: (2021)

LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer
por: Wang, Dejie, et al.
Publicado: (2015)

FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma
por: Quan, Lian-Jiao, et al.
Publicado: (2019)

Epigenetic regulation of EIF4A1 through DNA methylation and an oncogenic role of eIF4A1 through BRD2 signaling in prostate cancer
por: Wang, Chao, et al.
Publicado: (2022)

lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2
por: Mao, Wenjun, et al.
Publicado: (2022)

The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma
por: Chen, Shuo, et al.
Publicado: (2017)

Erratum to “lncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2”
por: Mao, Wenjun, et al.
Publicado: (2022)

MAFG‐AS1 promotes tumor progression via regulation of the HuR/PTBP1 axis in bladder urothelial carcinoma
por: Xiao, Mengqing, et al.
Publicado: (2020)

Research progresses in roles of LncRNA and its relationships with breast cancer
por: Bin, Xu, et al.
Publicado: (2018)

LncRNA SNHG3, a potential oncogene in human cancers
por: Xu, Bin, et al.
Publicado: (2020)

lncRNA PVT1: a novel oncogene in multiple cancers
por: Li, Ruiming, et al.
Publicado: (2022)

LncRNA AFAP1-AS1 is a prognostic biomarker and serves as oncogenic role in retinoblastoma
por: Hao, Fengqin, et al.
Publicado: (2018)

Enzalutamide-resistant related lncRNA NONHSAT210528 promotes the proliferation and invasion of prostate cancer
por: Ye, Chen, et al.
Publicado: (2022)

Androgen Receptor-Activated Enhancers Simultaneously Regulate Oncogene TMPRSS2 and lncRNA PRCAT38 in Prostate Cancer
por: Chen, Zikai, et al.
Publicado: (2019)

Identification of pyroptosis-related lncRNA signature and AC005253.1 as a pyroptosis-related oncogene in prostate cancer
por: Yu, JiangFan, et al.
Publicado: (2022)

LncRNA FOXD1‐AS1 acts as a potential oncogenic biomarker in glioma
por: Gao, Yuan‐Feng, et al.
Publicado: (2019)

Nrf2–MafG heterodimers contribute globally to antioxidant and metabolic networks
por: Hirotsu, Yosuke, et al.
Publicado: (2012)

lncRNA HIF1A-AS2: A potential oncogene in human cancers (Review)
por: Liu, Yang, et al.
Publicado: (2021)

Oncogenic LncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression
por: Hu, Qingsong, et al.
Publicado: (2019)

lncRNA Erbb4-IR is downregulated in prostate carcinoma and predicts prognosis
por: Zhou, Jiuyun, et al.
Publicado: (2020)

Specific expression of lncRNA RP13-650J16.1 and TCONS_00023979 in prostate cancer
por: Zhou, Xiaochen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n03q9256aa4488n7ljagls0ouk